High-Resolution 3D Printing Fabrication of a Microfluidic Platform for Blood Plasma Separation
- PMID: 35808588
- PMCID: PMC9269563
- DOI: 10.3390/polym14132537
High-Resolution 3D Printing Fabrication of a Microfluidic Platform for Blood Plasma Separation
Abstract
Additive manufacturing technology is an emerging method for rapid prototyping, which enables the creation of complex geometries by one-step fabrication processes through a layer-by-layer approach. The simplified fabrication achieved with this methodology opens the way towards a more efficient industrial production, with applications in a great number of fields such as biomedical devices. In biomedicine, blood is the gold-standard biofluid for clinical analysis. However, blood cells generate analytical interferences in many test procedures; hence, it is important to separate plasma from blood cells before analytical testing of blood samples. In this research, a custom-made resin formulation combined with a high-resolution 3D printing methodology were used to achieve a methodology for the fast prototype optimization of an operative plasma separation modular device. Through an iterative process, 17 different prototypes were designed and fabricated with printing times ranging from 5 to 12 min. The final device was evaluated through colorimetric analysis, validating this fabrication approach for the qualitative assessment of plasma separation from whole blood. The 3D printing method used here demonstrates the great contribution that this microfluidic technology will bring to the plasma separation biomedical devices market.
Keywords: 3D printing; fabrication; high resolution; plasma separation; stereolithography; whole blood.
Conflict of interest statement
The authors declare the following competing financial interest: G.P.N. and A.T.W. own shares in Acrea 3D, a company that is commercializing microfluidic 3D printing.
Figures
References
Grants and funding
- 778001 (DNASurf)/European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant
- R01 EB027096 and GM123405-A1/US National Institutes of Health
- Grant IT1271-19/Basque Government
- R15 GM123405/GM/NIGMS NIH HHS/United States
- R01 EB027096/EB/NIBIB NIH HHS/United States
LinkOut - more resources
Full Text Sources
